PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Neuroimaging Research Unit, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy.\', \'Multiple Sclerosis Center of the Veneto Region, Department of Neurosciences, University Hospital-School of Medicine, Padua, Italy.\', \'Neurology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.\', \'Neurorehabilitation Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.\', \'Neurophysiology Service, IRCCS San Raffaele Scientific Institute, Milan, Italy.\', \'Vita-Salute San Raffaele University, 20132, Milan, Italy.\', \'Neuroimaging Research Unit, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy. rocca.mara@hsr.it.\', \'Neurology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy. rocca.mara@hsr.it.\', \'Vita-Salute San Raffaele University, 20132, Milan, Italy. rocca.mara@hsr.it.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1007/s00415-021-10744-x
?:hasPublicationType
?:journal
  • Journal of neurology
is ?:pmid of
?:pmid
?:pmid
  • 34382120
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.626
?:rankingScore_hIndex
  • 118
?:title
  • Anti-CD20 therapies for multiple sclerosis: current status and future perspectives.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all